Obalon Therapeutics, Inc.

Reshape Lifesciences Inc.

Amy D L VandenBerg

Mark C Brister

Neil R Drake

Andrew P Rasdal

Antonio C Llevares

Dubravka Markovic

Matthew S Lake

Josefina Nider

Paul D Faucher

Nelson Quintana

Kaushik Aroonkumar Patel

Sheldon Nelson

Daniel J Proctor

Betty Wong

Keoni John Sundseth

Dubravka Markvoic

Devices and methods for treating obesity are provided. More particularly, intragastric devices and methods of fabricating, deploying, inflating, monitoring, and retrieving the same are provided.

Intragastric device

Intragastric volume-occupying devices and methods for treating obesity are provided. The devices, which are inflated by carbon dioxide, include an aluminum or silicon oxide barrier layer providing carbon dioxide retention and an alkylene vinyl alcohol polymer layer providing structural integrity in vivo.

Intragastric volume-occupying device and method for fabricating same

An implant configured for ingestion by a patient. After the implant has been swallowed by the patient and is disposed within the target location, e.g. the patient's stomach, an inflation subcomponent causes the implant to expand from a compact delivery state to an expanded, volume-occupying, deployed state. In the deployed state the implant creates a sensation of satiety in the patient stomach and thereby aids in limiting food intake and obesity. After a predetermined time a deflation subcomponent is actuated and the implant reduces in size so as to allow it to pass through the remainder of the patient's digestive track. The device may further incorporate tracking and visualization subcomponents, as well as pharmaceutical delivery subcomponents.

Intragastric device system

Growing community of inventors

San Diego, CA, United States of America

Amy D L VandenBerg